Your browser doesn't support javascript.
loading
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens.
Sachdeva, K S; Arora, N; Solanki, R; Singla, R; Sarin, R; Bhatnagar, A; Khanna, A; Atahavale, A; Shridhar, R; Barua, S R; Parmar, M; Farooq, S I; Ramachandran, R; Alavadi, U; Swamickan, R; Tonsing, J; Patel, Y; Singla, N.
Affiliation
  • Sachdeva KS; Central TB Division, Ministry of Health and Family Welfare, Government of India, New Delhi.
  • Arora N; International Union Against Tuberculosis and Lung Disease South East Asia, New Delhi.
  • Solanki R; BJ Medical College and Hospital, Ahmedabad.
  • Singla R; National Institute for TB and Respiratory Disease, New Delhi.
  • Sarin R; National Institute for TB and Respiratory Disease, New Delhi.
  • Bhatnagar A; Rajan Babu Institute for Pulmonary Medicine and Tuberculosis, New Delhi.
  • Khanna A; Government of National Capital Territory of Delhi, New Delhi.
  • Atahavale A; King Edward Memorial College & Group of TB Hospital, Mumbai.
  • Shridhar R; Government Hospital of Thoracic Medicine, Chennai.
  • Barua SR; Guwahati Medical College, Guwahati.
  • Parmar M; World Health Organisation, India Country Office, New Delhi.
  • Farooq SI; International Union Against Tuberculosis and Lung Disease South East Asia, New Delhi.
  • Ramachandran R; World Health Organisation, India Country Office, New Delhi.
  • Alavadi U; United States Agency for International Development India, New Delhi, India.
  • Swamickan R; United States Agency for International Development India, New Delhi, India.
  • Tonsing J; International Union Against Tuberculosis and Lung Disease South East Asia, New Delhi.
  • Patel Y; Central TB Division, Ministry of Health and Family Welfare, Government of India, New Delhi.
  • Singla N; National Institute for TB and Respiratory Disease, New Delhi.
Int J Tuberc Lung Dis ; 24(10): 1067-1072, 2020 10 01.
Article in En | MEDLINE | ID: mdl-33126941

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 3_ND Database: MEDLINE Main subject: Pharmaceutical Preparations / Tuberculosis, Multidrug-Resistant Limits: Humans Country/Region as subject: Asia Language: En Journal: Int J Tuberc Lung Dis Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 3_ND Database: MEDLINE Main subject: Pharmaceutical Preparations / Tuberculosis, Multidrug-Resistant Limits: Humans Country/Region as subject: Asia Language: En Journal: Int J Tuberc Lung Dis Year: 2020 Document type: Article